Apollo Senior Floating Rate Fund(AFT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

AFT Apollo Senior Floating Rate Fund

盘前交易 02-10 05:01:28 EST

14.86

+0.00

0.00%

最高14.86	最低14.86	成交量0.00
今开14.86	昨收14.86	日振幅0.00%
总市值2.31亿	流通市值0.00	总股本1,557万
成交额0.00	换手率--	流通股本0.00
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"AFT","market":"US","secType":"STK","nameCN":"Apollo Senior Floating Rate Fund","latestPrice":14.86,"timestamp":1767992400000,"preClose":14.86,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":0,"shares":15573575,"eps":2.309245,"marketStatus":"盘前交易","change":0,"latestTime":"02-10 05:01:28 EST","open":14.86,"high":14.86,"low":14.86,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":2.309245,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770733800000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":14.86,"dividendRate":0.098991,"volumeRatio":0},"requestUrl":"/m/hq/s/AFT/wiki","defaultTab":"wiki","newsList":[{"id":"2607709838","title":"港股异动 | 兆科眼科-B(06622)盘中涨超7% 公司扩大与AFT的合作至新加坡 与千寿达成越南合作协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2607709838","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607709838?lang=zh_cn&edition=full","pubTime":"2026-01-29 15:56","pubTimestamp":1769673400,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，兆科眼科-B盘中涨超7%，截至发稿，涨3.44%，报3.61港元，成交额1143.15万港元。消息面上，1月26日，兆科眼科宣布，将其核心老花眼治疗药物BRIMOCHOL PF在新加坡和越南的独家商业化权利，分别授予新西兰的AFT Pharmaceuticals和日本的千寿制药。至此，兆科眼科其全球化商业版图已延伸至韩国、澳洲、新西兰、泰国、印度尼西亚、台湾地区、新加坡和越南八个市场。根据协议，兆科眼科授予AFT在新加坡、授予千寿在越南的独家分销权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1399098.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK4585","AFT","06622","BK1587","BK1191","BK4588","BK1574","VT"],"gpt_icon":0},{"id":"2606279125","title":"港股异动 | 兆科眼科-B(06622)涨超5% 已扩大与AFT的伙伴协议 于新加坡商业化BRIMOCHOL™ PF","url":"https://stock-news.laohu8.com/highlight/detail?id=2606279125","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606279125?lang=zh_cn&edition=full","pubTime":"2026-01-27 11:02","pubTimestamp":1769482937,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，兆科眼科-B涨超5%，截至发稿，涨4.56%，报3.44港元，成交额170.7万港元。消息面上，1月26日，兆科眼科-B发布公告，公司已扩大与领先健康护理产品制造商及分销商AFT Pharmaceuticals Limited的伙伴协议，以于新加坡商业化BRIMOCHOL PF。兆科分别授予AFT及千寿于新加坡及越南的独家分销权，当中包括于相关市场注册、进口、推广、分销、营销及销售BRIMOCHOL PF的权利。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1397766.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06622","BK1587","BK1574","AFT","BK1191","BK1583"],"gpt_icon":0},{"id":"2606187862","title":"兆科眼科-B(06622)透过与AFT及千寿建立伙伴关系，推动用于治疗老花眼的BRIMOCHOL™ PF于新加坡及越南的商业化进程","url":"https://stock-news.laohu8.com/highlight/detail?id=2606187862","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606187862?lang=zh_cn&edition=full","pubTime":"2026-01-26 16:47","pubTimestamp":1769417253,"startTime":"0","endTime":"0","summary":"智通财经APP讯，兆科眼科-B 公布，公司已扩大与领先健康护理产品制造商及分销商AFT Pharmaceuticals Limited的伙伴协议，以于新加坡商业化BRIMOCHOL PF。兆科分别授予AFT及千寿于新加坡及越南的独家分销权，当中包括于相关市场注册、进口、推广、分销、营销及销售BRIMOCHOL PF的权利。透过该等协议，AFT及千寿成为BRIMOCHOL PF的第七及第八名商业化伙伴，彰显公司进军全球的坚定承诺。于2025年6月，Tenpoint宣布，美国FDA已受理该药品的新药上市申请。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1397334.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1583","AFT","BK1587","06622","BK1191"],"gpt_icon":0},{"id":"2503593303","title":"港股异动 | 兆科眼科-B(06622)涨超6% 与AFT就旗下滴眼液订立分销及供应协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2503593303","media":"智通财经","labels":["corporation","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503593303?lang=zh_cn&edition=full","pubTime":"2025-01-14 11:09","pubTimestamp":1736824162,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，兆科眼科-B涨超6%，截至发稿，涨6.06%，报1.4港元，成交额299.09万港元。消息面上，兆科眼科昨日宣布，公司已与新西兰领先医疗健康产品生产及分销商AFT Pharmaceuticals Limited，就BRIMOCHOLTM PF订立分销及供应协议。根据协议条款，兆科眼科有权将BRIMOCHOLTM PF在澳洲及新西兰的独家分销权授予AFT，以代表公司在当地取得药品注册，并独家进口、推广、分销、营销及销售BRIMOCHOLTM PF。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1237206.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1587","AFT","06622","BK1583","BK1191","BK1574"],"gpt_icon":0},{"id":"2492532120","title":"等待新预算案之际 法国将推进3,000亿欧元政府债券发行计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2492532120","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492532120?lang=zh_cn&edition=full","pubTime":"2024-12-19 21:13","pubTimestamp":1734614021,"startTime":"0","endTime":"0","summary":"法国债务管理部门维持其2025年发行计划较最初目标不变。本月早些时候巴尼耶政府下台后，法国在等待新的预算案。　　法国国库署表示，扣除回购，明年将发行3000亿欧元政府债券。这符合10月宣布的最初计划中的预期，今年发行规模为2850亿欧元。　　在左翼和极右翼议员联手推翻巴尼耶政府后，法国陷入政治和财政动荡。这位前任总理计划通过600亿欧元的增税和削减支出，将2025年预算赤字与经济产值之比从今年的6.1%缩小到5%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/world/2024-12-19/doc-inczzcmi7013703.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina_us","symbols":["AFT"],"gpt_icon":0},{"id":"2489283667","title":"海南海药(000566.SZ)与新西兰AFT就相关产品独家商业化权益达成合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2489283667","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489283667?lang=zh_cn&edition=full","pubTime":"2024-12-06 19:27","pubTimestamp":1733484438,"startTime":"0","endTime":"0","summary":"智通财经APP讯，海南海药 发布公告，公司全资子公司海南海药销售有限公司近日与AFT Pharmaceuticals Ltd.签署了《独家供应和分销协议》，双方主要就AFT的Lipo-Sachets脂质体维生素 C、Lipo-Sachets 脂质体维生素 D3、Ferro Lipo-Sachets补铁剂以及Kiwisoothe奇异舒咀嚼片四款产品在中国境内的商业化达成合作。AFT同意授予海药销售独家经销权，在合作区域内营销、销售和分销产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1221622.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0070","BK0060","AFT","BK0146","000566","BK0188","BK0239"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.apollofunds.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0021},{"period":"1month","weight":-0.0002},{"period":"3month","weight":0.016},{"period":"6month","weight":0.0761},{"period":"1year","weight":0.1551},{"period":"ytd","weight":0.0176}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Apollo Senior Floating Rate Fund Inc.于2011年2月23日在马里兰注册成立。这是一家多元化、封闭式管理投资公司。其投资目标是寻求当前收入和保本。他们旨在通过主要投资于向债务评级低于投资级别的公司提供的高级担保贷款和具有类似特征的投资来实现其投资目标。","yearOnYearQuotes":[{"month":1,"riseRate":0.769231,"avgChangeRate":0.01613},{"month":2,"riseRate":0.692308,"avgChangeRate":0.00429},{"month":3,"riseRate":0.571429,"avgChangeRate":-0.007473},{"month":4,"riseRate":0.428571,"avgChangeRate":0.004412},{"month":5,"riseRate":0.285714,"avgChangeRate":-0.008075},{"month":6,"riseRate":0.5,"avgChangeRate":-0.001455},{"month":7,"riseRate":0.642857,"avgChangeRate":0.002176},{"month":8,"riseRate":0.384615,"avgChangeRate":-0.011824},{"month":9,"riseRate":0.461538,"avgChangeRate":-0.009158},{"month":10,"riseRate":0.230769,"avgChangeRate":-0.006943},{"month":11,"riseRate":0.538462,"avgChangeRate":0.004362},{"month":12,"riseRate":0.307692,"avgChangeRate":-0.001312}],"exchange":"NYSE","name":"Apollo Senior Floating Rate Fund","nameEN":"Apollo Senior Floating Rate Fund"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Apollo Senior Floating Rate Fund(AFT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Apollo Senior Floating Rate Fund(AFT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Apollo Senior Floating Rate Fund,AFT,Apollo Senior Floating Rate Fund股票,Apollo Senior Floating Rate Fund股票老虎,Apollo Senior Floating Rate Fund股票老虎国际,Apollo Senior Floating Rate Fund行情,Apollo Senior Floating Rate Fund股票行情,Apollo Senior Floating Rate Fund股价,Apollo Senior Floating Rate Fund股市,Apollo Senior Floating Rate Fund股票价格,Apollo Senior Floating Rate Fund股票交易,Apollo Senior Floating Rate Fund股票购买,Apollo Senior Floating Rate Fund股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Apollo Senior Floating Rate Fund(AFT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Apollo Senior Floating Rate Fund(AFT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}